BofA downgraded Omega Healthcare to Neutral from Buy with a price target of $31, down from $33. The downgrade reflects the view of the stock’s more limited upside given continued tenant issues, “choppy” external growth and the risk to the dividend, the analyst tells investors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OHI:
